Monday, March 17, 2025 | 07:06 AM ISTहिंदी में पढें

Home / Markets / News / Sensex, Nifty extend record run on vaccine booster; Ultratech Cement up 4%

Sensex, Nifty extend record run on vaccine booster; Ultratech Cement up 4%

European equities marched higher after the UK became the first country to approve the Covid-19 vaccine developed by AstraZeneca and Oxford University

Premium

After succumbing to profit-booking in afternoon trade, the Sensex closed up by 133.14 points or 0.28 per cent at a record high of 47,746.22. The barometer scaled its all-time intra-day high of 47,807.85 | Photo: Bloomberg

Press Trust of India Mumbai

3 min read Last Updated : Dec 31 2020 | 12:42 AM IST

The Sensex and Nifty raced to fresh record highs on Wednesday as gains in financials, auto, and cement counters helped benchmarks extend their winning run for the sixth straight session amid positive global cues.

European equities marched higher after the UK became the first country to approve the Covid-19 vaccine developed by AstraZeneca and Oxford University.

Serum Institute of India (SII) termed the approval as encouraging news and said the company would now wait for the final nod for the vaccine in India.

After succumbing to profit-booking in afternoon trade, the Sensex closed up by 133.14 points or 0.28 per cent at a

Topics : Markets Sensex Nifty Coronavirus Vaccine stock market trading UltraTech

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in